# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 515 results.
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Mar 13, 2018
Disease(s): Sarcoma
Intervention(s): nivolumab, ipilimumab
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Dec 04, 2019
First Received: Apr 01, 2019
Disease(s): Sarcoma
Intervention(s): Blood Test - Stage 2-3 Sarcomas Preoperative RT, Blood Test - Stage 2-3 Sarcomas Postoperative RT, Blood Test - Stage 4 Sarcomas, Biopsy Sample of Tumor
Locations: Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Status: Not yet recruiting
Last Changed: Nov 22, 2019
First Received: Jul 30, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Gemcitabine, Docetaxel, Radiation, Surgical Resection, Blood draws
Locations: Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Palbociclib + Ganitumab In Ewing Sarcoma
Status: Recruiting
Last Changed: Dec 12, 2019
First Received: Oct 16, 2019
Disease(s): Ewing Sarcoma, Ewing's Sarcoma Recurrent
Intervention(s): Palbociclib, Ganitumab
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients
Status: Recruiting
Last Changed: Sep 17, 2019
First Received: Jun 14, 2019
Disease(s): Sarcoma, Soft Tissue
Intervention(s): Olaratumab and Trabectedin, Olaratumab and Trabectedin, Olaratumab and Trabectedin
Locations: GEIS, Madrid, Spain
FAZA PET/MRI Sarcoma
Status: Recruiting
Last Changed: Apr 25, 2019
First Received: Feb 01, 2018
Disease(s): Sarcoma
Intervention(s): 18F-FAZA
Locations: University Health Network, Toronto, Ontario, Canada
Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
Status: Not yet recruiting
Last Changed: May 10, 2019
First Received: Dec 20, 2018
Disease(s): Sarcoma
Intervention(s): Autologous CIK Dose level 1, Autologous CIK Dose level 2, Autologous CIK Dose level 3, Autologous CIK Dose level 4
Locations: Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology, Torino, Italy
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
Status: Recruiting
Last Changed: Sep 18, 2018
First Received: Jun 01, 2016
Disease(s): Soft-tissue Sarcoma
Intervention(s): Olaparib, Concomitant Radiotherapy
Locations: Institut Bergonié, Bordeaux, France
Centre Oscar Lambret, Lille, France
Centre Léon Bérard, Lyon, France
Institut du Cancer de Montpellier, Montpellier, France
Institut Claudius Regaud - IUCT, Toulouse, France
... and 2 other locations.
Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall
Status: Recruiting
Last Changed: Jan 25, 2019
First Received: Dec 18, 2015
Disease(s): Soft Tissue Sarcoma
Intervention(s): Hypofractionated Radiation Therapy
Locations: Froedtert Hospital, Milwaukee, Wisconsin, United States
Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.
Status: Not yet recruiting
Last Changed: May 10, 2019
First Received: Feb 12, 2019
Disease(s): Advanced Soft Tissue Sarcoma
Intervention(s): Standard arm: Trabectedin in monotherapy, Experimental arm: Trabectedin + Olaparib
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, MI, Italy
Istituto Europeo di Oncologia, Milano, MI, Italy
Istituto Clinico Humanitas, Rozzano, MI, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
Centro di Riferimento Oncologico di Aviano, Aviano, PD, Italy
... and 7 other locations.